Search

Your search keyword '"Ophthalmic drugs -- Intellectual property"' showing total 315 results
Start Over Descriptor "Ophthalmic drugs -- Intellectual property"
315 results on '"Ophthalmic drugs -- Intellectual property"'

1. Patent Issued for Implantable ocular drug delivery devices (USPTO 12102560)

Subjects
Drugs -- Vehicles, Prosthesis -- Intellectual property, Implants, Artificial -- Intellectual property, Ophthalmic drugs -- Intellectual property, Drug delivery systems -- Intellectual property, Physical fitness, Health
Abstract

2024 OCT 26 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors [...]

Published
2024

8. Researchers Submit Patent Application, 'Use Of High Molecular Weight Hyaluronic Acid As Ocular Transporting Vehicle', for Approval (USPTO 20230338541)

Subjects
Hyaluronic acid -- Intellectual property, Hydrochloric acid, Patient compliance, Ophthalmic drugs -- Intellectual property, Glaucoma, Ethylenediaminetetraacetic acid -- Intellectual property, Allergic reaction, Allergy, Physical fitness, Health
Abstract

2023 NOV 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2023

10. 'Ocular Lubricant Formulations' in Patent Application Approval Process (USPTO 20240197773)

Subjects
Eye diseases, Ophthalmic drugs -- Intellectual property, Amino acids -- Intellectual property, Lubrication and lubricants -- Intellectual property, Business, Health
Abstract

2024 JUL 12 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- A patent application by the inventors Hanrahan, Michael (Portland, OR, US); Stringer, William [...]

Published
2024

12. Peptide therapeutics are being introduced into ophthalmology: New option a potential treatment for patents diagnosed with dry eye disease

Author

Charters, Lynda

Subjects
Eye diseases, Homeopathy -- Materia medica and therapeutics, Ophthalmic drugs -- Intellectual property, Therapeutics -- Intellectual property, Patents, Peptides, Patent/copyright issue, Health
Abstract

Reviewed by Robert Yu YP-P10 (Yuyu Pharma), a novel, patented synthetic peptide, is being evaluated for safety, tolerability, and efficacy in the phase 2 clinical trial ICECAP 1 (NCT05467293). Yuyu [...]

Published
2023

13. Patent Issued for Implantable ocular drug delivery devices (USPTO 11617680)

Subjects
Drugs -- Vehicles, Prosthesis -- Intellectual property, Implants, Artificial -- Intellectual property, Ophthalmic drugs -- Intellectual property, Drug delivery systems -- Intellectual property, Physical fitness, Health
Abstract

2023 APR 29 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a [...]

Published
2023

14. 'Anterior Segment Drug Delivery' in Patent Application Approval Process (USPTO 20230102547)

Subjects
Tetracycline -- Intellectual property, Nonsteroidal anti-inflammatory drugs, Patient compliance, Fluocinolone acetonide, Fluocinolone, Drug approval, Drug delivery systems -- Intellectual property, Physical fitness, Emedastine -- Intellectual property, Levobetaxolol -- Intellectual property, Drugs -- Vehicles, Medrysone -- Intellectual property, Epinastine -- Intellectual property, Olopatadine hydrochloride -- Intellectual property, Ophthalmic drugs -- Intellectual property, Tetracyclines -- Intellectual property, Health
Abstract

2023 APR 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent application by the inventors Alejandro, Jose D. (North Chicago, IL, [...]

Published
2023

15. Patent Application Titled 'Ophthalmic Drug Sustained Release Formulation And Uses Thereof' Published Online (USPTO 20230091568)

Subjects
Patient compliance, Ophthalmic drugs -- Intellectual property, Fluocinolone acetonide, Nepafenac, Difluprednate, Fluocinolone, Bromfenac -- Intellectual property, Physical fitness, Health
Abstract

2023 APR 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2023

19. 'Storage And Carrying Device For Efficient Management Of Single-Use Eye Drop Vials' in Patent Application Approval Process (USPTO 20240139068)

Subjects
Ophthalmic drugs -- Intellectual property, Computer storage device industry -- Intellectual property, Company business management, Government, Political science
Abstract

2024 MAY 23 (VerticalNews) -- By a News Reporter-Staff News Editor at Politics & Government Week -- A patent application by the inventor Krygiel, Mary (Ashburn, VA, US), filed on [...]

Published
2024

21. Allergan's Trademark Application for 'BETAGAN' Filed

Subjects
Allergan PLC -- Intellectual property, Trademarks, Ophthalmic drugs -- Intellectual property, Pharmaceutical industry -- Intellectual property, Business, Pharmaceuticals and cosmetics industries, Health, Betagan (Medication) -- Intellectual property
Abstract

2024 APR 15 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application [...]

Published
2024

22. Patent Issued for Ocular lubricant formulations (USPTO 11918603)

Subjects
Eye diseases, Ophthalmic drugs -- Intellectual property, Amino acids -- Intellectual property, Lubrication and lubricants -- Intellectual property, Business, Health
Abstract

2024 MAR 29 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- Harrow IP LLC (Nashville, Tennessee, United States) has been issued patent number 11918603, [...]

Published
2024

23. An Application for the Trademark 'OSEEA' Has Been Filed by AbbVie

Subjects
Trademarks, Ophthalmic drugs -- Intellectual property, Pharmaceutical biotechnology, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 MAR 27 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has [...]

Published
2024

26. Patent Issued for Eye drop composition (USPTO 11904024)

Subjects
Ophthalmic drugs -- Intellectual property, Pharmaceutical biotechnology, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 MAR 13 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Auwerx, Joeri (Bierbeek, [...]

Published
2024

29. Patent Issued for Oleogel compositions for retinal drug delivery (USPTO 11406594)

Subjects
Drugs -- Vehicles, Ophthalmic drugs -- Intellectual property, Drug delivery systems -- Intellectual property, Physical fitness, Health
Abstract

2022 SEP 3 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors [...]

Published
2022

30. AbbVie's Trademark Application for 'EYVUE' Filed

Subjects
Trademarks, Ophthalmic drugs -- Intellectual property, Pharmaceutical biotechnology, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 FEB 28 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has [...]

Published
2024

33. Trademark Application for 'REFRESH PLUS' Filed by Allergan

Subjects
Allergan PLC -- Intellectual property, Trademarks, Ophthalmic drugs -- Intellectual property, Pharmaceutical industry -- Intellectual property, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2024 JAN 8 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application [...]

Published
2024

34. Delhi HC issues favourable order to Novartis on its divisional patent application for dry eye disease drug

Subjects
Novartis AG -- Intellectual property, Eye diseases, Ophthalmic drugs -- Intellectual property, Pharmaceuticals and cosmetics industries, Xiidra (Medication) -- Intellectual property
Abstract

Byline: Gireesh Babu The Delhi High Court has set aside an order by the Patent Office dismissing a patent application of Swiss pharma major Novartis AG, for its composition for [...]

Published
2022

35. Patent office rejects IP Alliance's pre grant opposition; grants patent to Alcon Research's ophthalmic drug

Subjects
Novartis AG -- Intellectual property, Research grants, Grants-in-aid, Olopatadine hydrochloride -- Intellectual property, Ophthalmic drugs -- Intellectual property, Pharmaceutical industry -- Intellectual property, Pharmaceuticals and cosmetics industries
Abstract

Byline: Gireesh Babu Indian patent office has approved the patent application of Alcon Research Ltd, the eye care devices business spun off from Swiss pharma major Novartis in 2019, for [...]

Published
2022

36. Patent Issued for Bioresorbable ocular drug delivery device (USPTO 11318043)

Subjects
Drugs -- Vehicles, Ophthalmic drugs -- Intellectual property, Drug delivery systems -- Intellectual property, Physical fitness, Health
Abstract

2022 MAY 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent by the inventors Burns, Thomas W. (Dana Point, CA, US), [...]

Published
2022

38. Researchers Submit Patent Application, 'Spray Ejector Mechanisms And Devices Providing Charge Isolation And Controllable Droplet Charge, And Low Dosage Volume Ophthalmic Administration', for Approval (USPTO 20220062035)

Subjects
Ophthalmic drugs -- Intellectual property, Physical fitness, Health
Abstract

2022 MAR 26 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2022

41. Patent Issued for Eye drop dispensement aid (USPTO 11213424)

Subjects
Patient compliance, Ophthalmic drugs -- Intellectual property, Glaucoma, Physical fitness, Health
Abstract

2022 JAN 29 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent by the inventors Kinast, Robert (Portland, OR, US), filed on [...]

Published
2022

43. Patent Issued for Preservative containing compositions (USPTO 11202832)

Subjects
Ophthalmic drugs -- Intellectual property, Antifungal agents -- Intellectual property, Physical fitness, Health
Abstract

2022 JAN 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors [...]

Published
2022

44. Researchers Submit Patent Application, 'Ocular Lubricant Formulations', for Approval (USPTO 20210315924)

Subjects
Eye diseases, Ophthalmic drugs -- Intellectual property, Povidone -- Intellectual property, Amino acids -- Intellectual property, Lubrication and lubricants -- Intellectual property, Physical fitness, Health
Abstract

2021 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2021

45. Patent Issued for Anti-microbial bandage contact lens with ocular drug delivery (USPTO 11086049)

Subjects
Drugs -- Vehicles, Contact lenses -- Intellectual property, Ophthalmic drugs -- Intellectual property, Drug delivery systems -- Intellectual property, Physical fitness, Health
Abstract

2021 SEP 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors [...]

Published
2021

46. Patent Issued for Multi-dose ocular fluid delivery system (USPTO 11679028)

Subjects
Novartis AG -- Intellectual property, Ophthalmic drugs -- Intellectual property, Pharmaceutical industry -- Intellectual property, Business, Health
Abstract

2023 JUL 14 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent [...]

Published
2023

49. Patent Application Titled 'Anterior Segment Drug Delivery' Published Online (USPTO 20210128351)

Subjects
Tetracycline -- Intellectual property, Methyltestosterone -- Intellectual property, Nonsteroidal anti-inflammatory drugs, Patient compliance, Fluocinolone acetonide, Tromethamine -- Intellectual property, Fluocinolone, Drug delivery systems -- Intellectual property, Physical fitness, Emedastine -- Intellectual property, Levobetaxolol -- Intellectual property, Drugs -- Vehicles, Medrysone -- Intellectual property, Epinastine -- Intellectual property, Olopatadine hydrochloride -- Intellectual property, Ophthalmic drugs -- Intellectual property, Tetracyclines -- Intellectual property, Health
Abstract

2021 JUN 19 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2021

50. Patent Issued for Ocular Drug Delivery System And Uses (USPTO 10,966,955)

Subjects
Besifloxacin, Drugs -- Vehicles, Ophthalmic drugs -- Intellectual property, Nepafenac, Bromfenac -- Intellectual property, Drug delivery systems -- Intellectual property, Physical fitness, Health
Abstract

2021 APR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent by the inventors Lai, Jui-Yang (Taoyuan, TW); Luo, Li-Jyuan (Taoyuan, [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results